James DiNicolantonio

Summary

Publications

  1. doi request reprint Carvedilol: a third-generation β-blocker should be a first-choice β-blocker
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca, NY 14850, USA
    Expert Rev Cardiovasc Ther 10:13-25. 2012
  2. doi request reprint Hypertension Due to Toxic White Crystals in the Diet: Should We Blame Salt or Sugar?
    James J Dinicolantonio
    Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Prog Cardiovasc Dis . 2016
  3. pmc The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease
    James J Dinicolantonio
    Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Prog Cardiovasc Dis 58:464-72. 2016
  4. doi request reprint Dietary Salt Restriction in Heart Failure: Where Is the Evidence?
    James J Dinicolantonio
    Mid America Heart Institute at Saint Luke s Hospital, Kansas City, MO, USA Electronic address
    Prog Cardiovasc Dis 58:401-6. 2016
  5. pmc Is fructose malabsorption a cause of irritable bowel syndrome?
    James J Dinicolantonio
    Department of Preventive Cardiology, Saint Luke s Mid America Heart Institute, Kansas City, MO, United States Electronic address
    Med Hypotheses 85:295-7. 2015
  6. doi request reprint Added fructose: a principal driver of type 2 diabetes mellitus and its consequences
    James J Dinicolantonio
    Department of Preventive Cardiology at Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Mayo Clin Proc 90:372-81. 2015
  7. ncbi request reprint Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
    James J Dinicolantonio
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, USA
    Mo Med 110:495-8. 2013
  8. doi request reprint Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting
    James J Dinicolantonio
    Department of Preventive Cardiology, Mid America Heart Institute at Saint Luke s Hospital, University of Missouri Kansas City, Kansas City, Missouri Electronic address
    Am J Cardiol 113:565-9. 2014
  9. doi request reprint Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, New York Electronic address
    Am J Cardiol 112:1230-4. 2013
  10. doi request reprint Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel
    James J Dinicolantonio
    Independent Researcher, Ithaca, NY, United States Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine, University Hospital Motol, Czech Republic Electronic address
    Int J Cardiol 169:145-6. 2013

Detail Information

Publications30

  1. doi request reprint Carvedilol: a third-generation β-blocker should be a first-choice β-blocker
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca, NY 14850, USA
    Expert Rev Cardiovasc Ther 10:13-25. 2012
    ..We will provide compelling evidence of why carvedilol should be a first-line β-blocker and why it offers many advantages over the β1-selective β-blockers...
  2. doi request reprint Hypertension Due to Toxic White Crystals in the Diet: Should We Blame Salt or Sugar?
    James J Dinicolantonio
    Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Prog Cardiovasc Dis . 2016
    ..Based on our review of the scientific literature, guidelines should focus more on reducing sugar rather than salt for the prevention and treatment of HTN and its consequences...
  3. pmc The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease
    James J Dinicolantonio
    Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Prog Cardiovasc Dis 58:464-72. 2016
    ....
  4. doi request reprint Dietary Salt Restriction in Heart Failure: Where Is the Evidence?
    James J Dinicolantonio
    Mid America Heart Institute at Saint Luke s Hospital, Kansas City, MO, USA Electronic address
    Prog Cardiovasc Dis 58:401-6. 2016
    ..To evaluate the strength of current evidences to recommend dietary salt restriction among HF patients, we performed a comprehensive literature review and explored the safety and efficacy of such recommendations. ..
  5. pmc Is fructose malabsorption a cause of irritable bowel syndrome?
    James J Dinicolantonio
    Department of Preventive Cardiology, Saint Luke s Mid America Heart Institute, Kansas City, MO, United States Electronic address
    Med Hypotheses 85:295-7. 2015
    ..This paper discusses the prevalence of fructose malabsorption and considers fructose ingestion as a possible cause of--and fructose restriction as a possible dietary treatment for--IBS. ..
  6. doi request reprint Added fructose: a principal driver of type 2 diabetes mellitus and its consequences
    James J Dinicolantonio
    Department of Preventive Cardiology at Saint Luke s Mid America Heart Institute, Kansas City, Mo Electronic address
    Mayo Clin Proc 90:372-81. 2015
    ..Reducing the intake of added sugars could translate to reduced diabetes-related morbidity and premature mortality for populations...
  7. ncbi request reprint Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
    James J Dinicolantonio
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, USA
    Mo Med 110:495-8. 2013
    ....
  8. doi request reprint Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting
    James J Dinicolantonio
    Department of Preventive Cardiology, Mid America Heart Institute at Saint Luke s Hospital, University of Missouri Kansas City, Kansas City, Missouri Electronic address
    Am J Cardiol 113:565-9. 2014
    ..50, 95% confidence interval 0.32 to 0.80). In conclusion, compared with metoprolol, carvedilol significantly reduces the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. ..
  9. doi request reprint Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, New York Electronic address
    Am J Cardiol 112:1230-4. 2013
    ....
  10. doi request reprint Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel
    James J Dinicolantonio
    Independent Researcher, Ithaca, NY, United States Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine, University Hospital Motol, Czech Republic Electronic address
    Int J Cardiol 169:145-6. 2013
    ..Ticagrelor, a novel, reversible, and oral P2Y12 receptor antagonist, was claimed to reduce all-cause mortality compared to clopidogrel in the PLATO trial...
  11. doi request reprint Dietary sodium restriction: take it with a grain of salt
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY Electronic address
    Am J Med 126:951-5. 2013
    ....
  12. doi request reprint Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, United States Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine, University Hospital Motol, Czech Republic Electronic address
    Int J Cardiol 168:4076-80. 2013
    ..Ascertain platelet inhibition and patient outcomes (PLATO) trial conduct...
  13. doi request reprint Thiamine supplementation for the treatment of heart failure: a review of the literature
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY 14850, USA
    Congest Heart Fail 19:214-22. 2013
    ..Therefore, this simple therapy should be tested in large-scale randomized clinical trial to further determine the effects of thiamine in HF patients. ..
  14. doi request reprint Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, United States Electronic address
    Int J Cardiol 168:1739-44. 2013
    ..To compare hemorrhagic events between clopidogrel and ticagrelor in the Platelet Inhibition and Patient Outcomes (PLATO) trial...
  15. doi request reprint Refuting the ticagrelor-aspirin black box warning: and proposing a ticagrelor early-PCI black box warning
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca NY 14850, United States Electronic address
    Int J Cardiol 168:1721-3. 2013
    ..Ticagrelor, a novel reversible antiplatelet agent, has a black box warning to avoid maintenance doses of aspirin>100mg. However, a significant ticagrelor-early percutaneous coronary intervention (PCI) interaction exists...
  16. doi request reprint Challenging ticagrelor's claimed reduction in the rate of definite stent thrombosis versus clopidogrel: insights from the FDA reports
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, USA Electronic address
    Int J Cardiol 168:633-5. 2013
    ..A statement that ticagrelor reduces definite stent thrombosis versus clopidogrel cannot be justified...
  17. doi request reprint Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, USA
    Postgrad Med 125:154-68. 2013
    ..Ramipril has an impressive track record of improving cardiovascular outcomes, too, and should be considered a preferred agent among the ACE inhibitor class. ..
  18. doi request reprint L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY 14850, USA
    Mayo Clin Proc 88:544-51. 2013
    ..To evaluate the effects of L-carnitine compared with placebo or control on morbidity and mortality in the setting of acute myocardial infarction...
  19. doi request reprint Exploring the reduction in myocardial infarctions in the PLATO trial: Which patients benefited on ticagrelor vs. clopidogrel?
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca, NY, 14850, United States Electronic address
    Int J Cardiol 165:396-7. 2013
    ..However, there was no explanation as to whether there was an equal distribution of benefit throughout acute coronary syndrome (ACS) types...
  20. doi request reprint Lost in follow-up rates in TRACER, ATLAS ACS 2, TRITON and TRA 2P trials: Challenging PLATO mortality rates
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca, New York 14850, United States Electronic address
    Int J Cardiol 164:255-8. 2013
    ....
  21. pmc Challenging the FDA black box warning for high aspirin dose with ticagrelor in patients with diabetes
    James J Dinicolantonio
    Wegman s Pharmacy, Ithaca, New York, USA
    Diabetes 62:669-71. 2013
    ..The black box warning for the use of maintenance ASA doses >100 mg with ticagrelor is inappropriate for patients with diabetes and not evidence based...
  22. doi request reprint Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, USA
    Postgrad Med 125:7-16. 2013
    ..The recent availability of atorvastatin as a generic option gives this drug another practical and compelling advantage over rosuvastatin...
  23. doi request reprint Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY, USA
    Am J Cardiol 111:765-9. 2013
    ..Additionally, carvedilol significantly reduced all-cause mortality compared with β(1)-selective BBs in AMI patients using the fixed-effects model but not using the random-effects model...
  24. doi request reprint CoQ10 and L-carnitine for statin myalgia?
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street Ithaca, Ithaca, NY 14850, USA
    Expert Rev Cardiovasc Ther 10:1329-33. 2012
    ..The question of whether CoQ10 can help treat statin myopathy is a common one encountered by clinicians in current day practice...
  25. doi request reprint Angiotensin receptor blockers worsen renal function and dyspnea on ticagrelor: a potential ticagrelor-Angiotensin receptor blocker interaction?
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, New York
    Clin Cardiol 35:647-8. 2012
    ....
  26. ncbi request reprint Should torsemide be the loop diuretic of choice in systolic heart failure?
    James J Dinicolantonio
    Wegmans Pharmacy, Ithaca, NY 14850, USA
    Future Cardiol 8:707-28. 2012
    ..86 [0.53-1.39], p = 0.54). Compared with furosemide, torsemide significantly reduces HF and CV-related hospital readmissions in systolic HF. Furthermore, torsemide is associated with a trend in reducing all-cause mortality...
  27. doi request reprint Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street Ithaca, Ithaca, NY 14850, USA
    Expert Opin Pharmacother 13:1101-11. 2012
    ..This review will summarize the flaws of the RE-LY trial as well as the clinically important advantages and disadvantages of dabigatran and warfarin...
  28. doi request reprint Hydrochlorothiazide: is it a wise choice?
    James J Dinicolantonio
    Wegmans Pharmacy, 500 South Meadow Street, Ithaca, NY 14850, USA
    Expert Opin Pharmacother 13:807-14. 2012
    ..However, there are more clinical data for chlorthalidone and indapamide than HCTZ...